APO Research
Talk to an analyst

APO RESEARCH · REPORT

Foot and Mouth Disease (FMD) Vaccines

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Selected research

Market Structure

Global Foot and Mouth Disease (FMD) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchFoot and Mouth Disease (FMD) Vaccines Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Foot and Mouth Disease (FMD) Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Foot and Mouth Disease (FMD) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Foot and Mouth Disease (FMD) Vaccines Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Foot and Mouth Disease (FMD) Vaccines Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.

Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.

Read the full market overview

In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.

This report provides an overview of the global Foot and Mouth Disease (FMD) Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Foot and Mouth Disease (FMD) Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Foot and Mouth Disease (FMD) Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Foot and Mouth Disease (FMD) Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Foot and Mouth Disease (FMD) Vaccines Segment by Company

Jinyu Group

Cavet Bio

Indian Immunologicals

Tecon Group

CAHIC

Shen Lian

Biogenesis Bagó

BIGVET Biotech

Boehringer Ingelheim

MSD Animal Health

CEVA

FGBI

Bayer HealthCare

Brilliant Bio Pharma

VECOL

Sanofi (Merial)

VETAL

BVI

LIMOR

ME VAC

Agrovet

Foot and Mouth Disease (FMD) Vaccines Segment by Type

Emergency Vaccines

Conventional Vaccines

Foot and Mouth Disease (FMD) Vaccines Segment by Application

Cattle

Pig

Sheep and Goat

Others

Foot and Mouth Disease (FMD) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Foot and Mouth Disease (FMD) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Foot and Mouth Disease (FMD) Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Foot and Mouth Disease (FMD) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Foot and Mouth Disease (FMD) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Foot and Mouth Disease (FMD) Vaccines Industry Trends Table 2. Foot and Mouth Disease (FMD) Vaccines Industry Drivers Table 3. Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges Table 4. Foot and Mouth Disease (FMD) Vaccines Industry Restraints Table 5. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers Table 9. Global Foot and Mouth Disease (FMD) Vaccines Average Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 10. Global Foot and Mouth Disease (FMD) Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Foot and Mouth Disease (FMD) Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers, Product Type & Application Table 13. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Foot and Mouth Disease (FMD) Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Emergency Vaccines Table 17. Major Manufacturers of Conventional Vaccines Table 18. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 19. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 20. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027-2032) & (M Doses) Table 21. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 24. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2026) & (M Doses) Table 25. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2027-2032) & (M Doses) Table 26. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cattle Table 29. Major Manufacturers of Pig Table 30. Major Manufacturers of Sheep and Goat Table 31. Major Manufacturers of Others Table 32. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 33. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 34. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027-2032) & (M Doses) Table 35. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021-2026) Table 36. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2027-2032) Table 37. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 38. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2026) & (M Doses) Table 39. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2027-2032) & (M Doses) Table 40. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021-2026) Table 41. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2027-2032) Table 42. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 43. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2026) & (M Doses) Table 44. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2021-2026) Table 45. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecasted by Region (2027-2032) & (M Doses) Table 46. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 48. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 49. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 50. Europe Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 51. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 52. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 53. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 54. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 55. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 56. South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 57. South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 58. South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 59. Global Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2021-2026) Table 63. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2027-2032) Table 64. Jinyu Group Company Information Table 65. Jinyu Group Business Overview Table 66. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 68. Jinyu Group Recent Development Table 69. Cavet Bio Company Information Table 70. Cavet Bio Business Overview Table 71. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 73. Cavet Bio Recent Development Table 74. Indian Immunologicals Company Information Table 75. Indian Immunologicals Business Overview Table 76. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 78. Indian Immunologicals Recent Development Table 79. Tecon Group Company Information Table 80. Tecon Group Business Overview Table 81. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 83. Tecon Group Recent Development Table 84. CAHIC Company Information Table 85. CAHIC Business Overview Table 86. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 88. CAHIC Recent Development Table 89. Shen Lian Company Information Table 90. Shen Lian Business Overview Table 91. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 93. Shen Lian Recent Development Table 94. Biogenesis Bagó Company Information Table 95. Biogenesis Bagó Business Overview Table 96. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 98. Biogenesis Bagó Recent Development Table 99. BIGVET Biotech Company Information Table 100. BIGVET Biotech Business Overview Table 101. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 103. BIGVET Biotech Recent Development Table 104. Boehringer Ingelheim Company Information Table 105. Boehringer Ingelheim Business Overview Table 106. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 108. Boehringer Ingelheim Recent Development Table 109. MSD Animal Health Company Information Table 110. MSD Animal Health Business Overview Table 111. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 113. MSD Animal Health Recent Development Table 114. CEVA Company Information Table 115. CEVA Business Overview Table 116. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 118. CEVA Recent Development Table 119. FGBI Company Information Table 120. FGBI Business Overview Table 121. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 123. FGBI Recent Development Table 124. Bayer HealthCare Company Information Table 125. Bayer HealthCare Business Overview Table 126. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 128. Bayer HealthCare Recent Development Table 129. Brilliant Bio Pharma Company Information Table 130. Brilliant Bio Pharma Business Overview Table 131. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 133. Brilliant Bio Pharma Recent Development Table 134. VECOL Company Information Table 135. VECOL Business Overview Table 136. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 138. VECOL Recent Development Table 139. Sanofi (Merial) Company Information Table 140. Sanofi (Merial) Business Overview Table 141. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 143. Sanofi (Merial) Recent Development Table 144. VETAL Company Information Table 145. VETAL Business Overview Table 146. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 148. VETAL Recent Development Table 149. BVI Company Information Table 150. BVI Business Overview Table 151. BVI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 153. BVI Recent Development Table 154. LIMOR Company Information Table 155. LIMOR Business Overview Table 156. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 158. LIMOR Recent Development Table 159. ME VAC Company Information Table 160. ME VAC Business Overview Table 161. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 163. ME VAC Recent Development Table 164. Agrovet Company Information Table 165. Agrovet Business Overview Table 166. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 168. Agrovet Recent Development Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Foot and Mouth Disease (FMD) Vaccines Distributors List Table 172. Foot and Mouth Disease (FMD) Vaccines Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Foot and Mouth Disease (FMD) Vaccines Product Image Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Foot and Mouth Disease (FMD) Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Foot and Mouth Disease (FMD) Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Foot and Mouth Disease (FMD) Vaccines Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Top 5 and 10 Foot and Mouth Disease (FMD) Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Emergency Vaccines Image Figure 9. Conventional Vaccines Image Figure 10. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 11. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 14. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Cattle Image Figure 17. Pig Image Figure 18. Sheep and Goat Image Figure 19. Others Image Figure 20. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 21. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021-2032) Figure 23. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 24. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021-2032) Figure 26. North America Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 27. North America Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2032) Figure 28. U.S. Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. Canada Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Mexico Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 31. Europe Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 32. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2032) Figure 33. Germany Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. France Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. U.K. Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. Italy Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Netherlands Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 38. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 39. Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2032) Figure 40. China Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. Japan Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. South Korea Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. India Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. Australia Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 46. South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 47. South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2032) Figure 48. Brazil Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. South Africa Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. Turkey Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. Argentina Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. UAE Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Egypt Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 55. Chile Foot and Mouth Disease (FMD) Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 56. Global Foot and Mouth Disease (FMD) Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. North America Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Foot and Mouth Disease (FMD) Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Foot and Mouth Disease (FMD) Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Emergency Vaccines
  • Conventional Vaccines
Applications
  • Cattle
  • Pig
  • Sheep and Goat
  • Others
Companies covered
  • Jinyu Group
  • Cavet Bio
  • Indian Immunologicals
  • Tecon Group
  • CAHIC
  • Shen Lian
  • Biogenesis Bagó
  • BIGVET Biotech
  • Boehringer Ingelheim
  • MSD Animal Health
  • CEVA
  • FGBI
  • Bayer HealthCare
  • Brilliant Bio Pharma
  • VECOL
  • Sanofi (Merial)
  • VETAL
  • BVI
  • LIMOR
  • ME VAC
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Foot and Mouth Disease (FMD) Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Foot and Mouth Disease (FMD) Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Foot and Mouth Disease (FMD) Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Foot and Mouth Disease (FMD) Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Foot and Mouth Disease (FMD) Vaccines Market Dynamics
  1. 2.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
  2. 2.2 Foot and Mouth Disease (FMD) Vaccines Industry Drivers
  3. 2.3 Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges
  4. 2.4 Foot and Mouth Disease (FMD) Vaccines Industry Restraints
3 Foot and Mouth Disease (FMD) Vaccines Market by Manufacturers
  1. 3.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Foot and Mouth Disease (FMD) Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Foot and Mouth Disease (FMD) Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Foot and Mouth Disease (FMD) Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Foot and Mouth Disease (FMD) Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Foot and Mouth Disease (FMD) Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Foot and Mouth Disease (FMD) Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Foot and Mouth Disease (FMD) Vaccines Tier 1, Tier 2, and Tier 3
4 Foot and Mouth Disease (FMD) Vaccines Market by Type
  1. 4.1 Foot and Mouth Disease (FMD) Vaccines Type Introduction
  2. 4.1.1 Emergency Vaccines
  3. 4.1.2 Conventional Vaccines
  4. 4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type
  5. 4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type
  9. 4.3.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021-2032)
5 Foot and Mouth Disease (FMD) Vaccines Market by Application
  1. 5.1 Foot and Mouth Disease (FMD) Vaccines Application Introduction
  2. 5.1.1 Cattle
  3. 5.1.2 Pig
  4. 5.1.3 Sheep and Goat
  5. 5.1.4 Others
  6. 5.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application
  7. 5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2032)
  9. 5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021-2032)
  10. 5.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application
  11. 5.3.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2032)
  13. 5.3.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021-2032)
6 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region
  1. 6.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region
  1. 7.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region
  2. 7.1.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Jinyu Group
  2. 8.1.1 Jinyu Group Company Information
  3. 8.1.2 Jinyu Group Business Overview
  4. 8.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  6. 8.1.5 Jinyu Group Recent Developments
  7. 8.2 Cavet Bio
  8. 8.2.1 Cavet Bio Company Information
  9. 8.2.2 Cavet Bio Business Overview
  10. 8.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  12. 8.2.5 Cavet Bio Recent Developments
  13. 8.3 Indian Immunologicals
  14. 8.3.1 Indian Immunologicals Company Information
  15. 8.3.2 Indian Immunologicals Business Overview
  16. 8.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  18. 8.3.5 Indian Immunologicals Recent Developments
  19. 8.4 Tecon Group
  20. 8.4.1 Tecon Group Company Information
  21. 8.4.2 Tecon Group Business Overview
  22. 8.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  24. 8.4.5 Tecon Group Recent Developments
  25. 8.5 CAHIC
  26. 8.5.1 CAHIC Company Information
  27. 8.5.2 CAHIC Business Overview
  28. 8.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  30. 8.5.5 CAHIC Recent Developments
  31. 8.6 Shen Lian
  32. 8.6.1 Shen Lian Company Information
  33. 8.6.2 Shen Lian Business Overview
  34. 8.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  36. 8.6.5 Shen Lian Recent Developments
  37. 8.7 Biogenesis Bagó
  38. 8.7.1 Biogenesis Bagó Company Information
  39. 8.7.2 Biogenesis Bagó Business Overview
  40. 8.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  42. 8.7.5 Biogenesis Bagó Recent Developments
  43. 8.8 BIGVET Biotech
  44. 8.8.1 BIGVET Biotech Company Information
  45. 8.8.2 BIGVET Biotech Business Overview
  46. 8.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  48. 8.8.5 BIGVET Biotech Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
  55. 8.10 MSD Animal Health
  56. 8.10.1 MSD Animal Health Company Information
  57. 8.10.2 MSD Animal Health Business Overview
  58. 8.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  60. 8.10.5 MSD Animal Health Recent Developments
  61. 8.11 CEVA
  62. 8.11.1 CEVA Company Information
  63. 8.11.2 CEVA Business Overview
  64. 8.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  66. 8.11.5 CEVA Recent Developments
  67. 8.12 FGBI
  68. 8.12.1 FGBI Company Information
  69. 8.12.2 FGBI Business Overview
  70. 8.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  72. 8.12.5 FGBI Recent Developments
  73. 8.13 Bayer HealthCare
  74. 8.13.1 Bayer HealthCare Company Information
  75. 8.13.2 Bayer HealthCare Business Overview
  76. 8.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  78. 8.13.5 Bayer HealthCare Recent Developments
  79. 8.14 Brilliant Bio Pharma
  80. 8.14.1 Brilliant Bio Pharma Company Information
  81. 8.14.2 Brilliant Bio Pharma Business Overview
  82. 8.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  84. 8.14.5 Brilliant Bio Pharma Recent Developments
  85. 8.15 VECOL
  86. 8.15.1 VECOL Company Information
  87. 8.15.2 VECOL Business Overview
  88. 8.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  90. 8.15.5 VECOL Recent Developments
  91. 8.16 Sanofi (Merial)
  92. 8.16.1 Sanofi (Merial) Company Information
  93. 8.16.2 Sanofi (Merial) Business Overview
  94. 8.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  96. 8.16.5 Sanofi (Merial) Recent Developments
  97. 8.17 VETAL
  98. 8.17.1 VETAL Company Information
  99. 8.17.2 VETAL Business Overview
  100. 8.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  102. 8.17.5 VETAL Recent Developments
  103. 8.18 BVI
  104. 8.18.1 BVI Company Information
  105. 8.18.2 BVI Business Overview
  106. 8.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  108. 8.18.5 BVI Recent Developments
  109. 8.19 LIMOR
  110. 8.19.1 LIMOR Company Information
  111. 8.19.2 LIMOR Business Overview
  112. 8.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  114. 8.19.5 LIMOR Recent Developments
  115. 8.20 ME VAC
  116. 8.20.1 ME VAC Company Information
  117. 8.20.2 ME VAC Business Overview
  118. 8.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  120. 8.20.5 ME VAC Recent Developments
  121. 8.21 Agrovet
  122. 8.21.1 Agrovet Company Information
  123. 8.21.2 Agrovet Business Overview
  124. 8.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  126. 8.21.5 Agrovet Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis
  2. 9.1.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Foot and Mouth Disease (FMD) Vaccines Production Mode & Process
  6. 9.2 Foot and Mouth Disease (FMD) Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Foot and Mouth Disease (FMD) Vaccines Distributors
  9. 9.2.3 Foot and Mouth Disease (FMD) Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst